{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:17:23Z","timestamp":1770535043226,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.seizure.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:22:46Z","timestamp":1479914566000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies \u2014 A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center"],"prefix":"10.1016","volume":"45","author":[{"given":"Christoph","family":"Kurth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Kockelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard J.","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2016.11.012_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/WCO.0b013e3283292427","article-title":"Interpreting regulatory trials in epilepsy","volume":"22","author":"Marson","year":"2009","journal-title":"Curr Opin Neurol"},{"issue":"Feb (2)","key":"10.1016\/j.seizure.2016.11.012_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1528-1167.2010.02915.x","article-title":"Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis","volume":"52","author":"Rheims","year":"2011","journal-title":"Epilepsia"},{"issue":"Jul (7)","key":"10.1016\/j.seizure.2016.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1528-1167.2011.03047.x","article-title":"Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis","volume":"52","author":"Costa","year":"2011","journal-title":"Epilepsia"},{"issue":"Nov (11)","key":"10.1016\/j.seizure.2016.11.012_bib0020","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/epi.12765","article-title":"Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis","volume":"55","author":"Hemery","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 5","key":"10.1016\/j.seizure.2016.11.012_bib0025","first-page":"52","article-title":"Drug resistance and seizure severity of patients in partial-onset seizure registration trials of perampanel compared with recently approved antiepileptic drugs","volume":"53","author":"Krauss","year":"2012","journal-title":"Epilepsia"},{"issue":"Jul (5)","key":"10.1016\/j.seizure.2016.11.012_bib0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eplepsyres.2014.03.015","article-title":"A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria","volume":"108","author":"Steinhoff","year":"2014","journal-title":"Epilepsy Res"},{"issue":"Mar","key":"10.1016\/j.seizure.2016.11.012_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yebeh.2015.12.034","article-title":"Adjunctive retigabine in refractory focal epilepsy: postmarketing experience at four tertiary epilepsy care centers in Germany","volume":"56","author":"Nass","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"Jan\/Feb (s1)","key":"10.1016\/j.seizure.2016.11.012_bib0040","first-page":"233","article-title":"Long-term treatment of 107 patients with Lacosamide \u2014 experience of the Epilepsy Centre Kork (Germany)","volume":"12","author":"Kurth","year":"2012","journal-title":"Epilepsy Currents"},{"issue":"Jan (Suppl. 1)","key":"10.1016\/j.seizure.2016.11.012_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/epi.12492","article-title":"First clinical experiences with perampanel\u2014the Kork experience in 74 patients","volume":"55","author":"Steinhoff","year":"2014","journal-title":"Epilepsia"},{"issue":"Jan (1)","key":"10.1016\/j.seizure.2016.11.012_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/01.wnl.0000286959.22040.6e","article-title":"Quantifying the response to antiepileptic drugs: effect of past treatment history","volume":"70","author":"Schiller","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2016.11.012_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2014.11.007","article-title":"Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review","volume":"25","author":"Paquette","year":"2015","journal-title":"Seizure"},{"issue":"Mar (3)","key":"10.1016\/j.seizure.2016.11.012_bib0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ane.12529","article-title":"Perampanel for focal epilepsy: insights from early clinical experience","volume":"133","author":"Trinka","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2016.11.012_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2013.11.016","article-title":"Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses","volume":"31","author":"Brodie","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2016.11.012_bib0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ana.21064","article-title":"Results of treatment changes in patients with apparently drug-resistant chronic epilepsy","volume":"62","author":"Luciano","year":"2007","journal-title":"Ann Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116302382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116302382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:47:51Z","timestamp":1761011271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131116302382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":14,"alternative-id":["S1059131116302382"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.11.012","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies \u2014 A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}